CLINICAL_TRIALS
trial_result
· 2024-01-02
Clinical Trial Update: The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma [Phase 3]
Summary
A Phase 3 clinical trial update evaluating intralesional 5-fluorouracil for basal cell carcinoma is reported with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Aleppo | Conditions: Basal Cell Carcinoma, BCC | Phase 3 | Status: UNKNOWN